G. Guenther (Borstel, Germany), D. Cirillo (Milan, Italy), G. Bothamley (London, United Kingdom), S. Apetrei (Bucharest, Romania)
Predictive factors of relapse in pulmonary tuberculosis
S. Habibech, I. Zendah, K. Ayed, L. Bayahi, I. Kouaja, H. Ghedira (Ariana, Tunisia)
|  |
Relapse rate of tuberculosis and related factors in Korea; by using the nationwide tuberculosis notification data
H. Lee, Y.S. Park, J. Kim, E.H. Cho, S.S. Shin, B.Y. Choi (Osong, Seoul, Republic Of Korea)
|  |
The risk factors of the TB death among case of initial treatment failure and retreatment after default
Y.S. Park, S.J. Hong, S. Cho, H. An, H. Lee, E.H. Cho, S.S. Shin (Choongcheongbukdo, Seoul, Republic Of Korea)
| |
Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial
D. Madegedara, D. Yasaratne, C. Kulathinga, S. Wijesinghe, S. Alwis (Kandy, Colombo, Sri Lanka)
| |
C-reactive protein in pulmonary tuberculosis-correlation with extent and severity of the disease
N. Teixeira, H. Dabó, I. Gomes, A. Marques (Porto, Portugal)
| |
Diagnosing value of closed-pleural biopsy in pleural tuberculosis
B. Hamdi, C. Aichaouia, S. Mhamdi, Z. Moetamri, S. Daboussi, S. Farah, M. Khadhraoui, R. Cheikh (Tunis, Tunisia)
| |
Atypical pulmonary tuberculosis
W. Elkhattabi, A. Aichane, Z. Berrada, H. Afif, Z. Bouayad (Casablanca, Morocco)
| |
Features and treatment outcome in caseous pneumonia
E. Lesnic, O. Caraiani, V. Zlepca (Chisinau, Republic Of Moldova)
| |
How do we diagnose tuberculosis in early childhood?
I. Ladeira, A. Correia, I. Carvalho, A. Carvalho, R. Duarte (Vila Nova de Gaia, Porto, Portugal)
| |
Gender difference in sputum positive pulmonary TB cases
V. Kunjupillay, P.R. Sreelatha, R.S. Nisha (Alappuzha, India)
| |
Risk of serious adverse reactions during the treatment of new tuberculosis patients
D. Ivanova, S. Borisov, A. Ryzhov (Moscow, Russian Federation)
| |
Drug interaction in tuberculosis treatment – The role of pharmacists
N. Cebron Lipovec, J. Toni, P. Svetina Sorli, M. Kosnik (Golnik, Slovenia)
| |
The pharmacotherapy options for the intensive treatment phase in patients with primarily diagnosed pulmonary tuberculosis
M. Kuzhko, N. Hulchuk, M. Gumeniuk, M. Klymenko, O. Avramchuk, O. Denisov (Kiyv, Ukraine)
| |
Anti-tuberculosis therapy as a reason for ejaculatory disorders
E. Kulchavenya, E. Brizhatyuk, D. Kholtobin, A. Osadchyi (Novosibirsk, Russian Federation)
| |
Predictive factors for antituberculosis treatment failure
E. Lesnic, Z. Vasile (Chisinau, Republic Of Moldova)
| |
Incremental yield of first, second and third sputum acid fast bacilli smear by microscopy in the diagnosis of pulmonary tuberculosis among patients referred to St. Paul Hospital Iloilo Public Private Mix directly observed treatment shortcourse
K.K. Gayon, A.L. Ponje, E. Solis, R. Toledo III (Iloilo City, Philippines)
| |
Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
S. Wafy (Assiut, Egypt)
| |
Cutaneous tuberculosis: Two cases report
O.S. Içmeli, H. Türker, M. Çiftçi, B. Gündogus, M. Kavala (Istanbul, Turkey)
| |
Tuberculosis and tumor necrosis factor alpha antagonist: Our experience
N.M. Reina Marfil, E. Ortega Sáenz de Tejada, L. López López, A.M. Franco Torres, J.L. Velasco Garrido, C. Fernández Aguirre, M.V. Hidalgo Sanjuán (Malaga, Spain)
| |